Sopharma AD Logo

Sopharma AD

Pharmaceutical producer of Rx, OTC, and plant-based medicines for international markets.

SFA | BSOBGN

Overview

Corporate Details

ISIN(s):
BG11SOSOBT18
LEI:
097900BGGW0000048796
Country:
Bulgaria
Address:
ул. Лъчезар Станчев 5, кула А, ет.18, 1756 София

Description

Sopharma AD is a pharmaceutical company founded in 1933 that specializes in the production, distribution, and export of a wide range of medical products. The company's portfolio includes prescription (Rx) and over-the-counter (OTC) medicines, encompassing both branded and generic drugs. A key area of focus is its traditional plant-based products. Sopharma develops treatments for various conditions, including liver disease, pain management, and smoking cessation. Operating from EU-GMP certified facilities, the company also provides contract manufacturing services and has an established presence in over 40 international markets.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2016-07-21 15:55
Current report 68 buy back 21072016
Polish 34.5 KB
2016-07-18 12:09
Current report 67 re insiders transactions
Polish 56.0 KB
2016-07-14 14:27
Current report 66 buy back 14072016
Polish 38.5 KB
2016-07-11 15:40
Current report 65 re insiders transactions
Polish 60.0 KB
2016-07-11 15:30
Current report 64 re insiders transactions
Polish 56.0 KB
2016-07-05 16:36
Current report 63 re insiders transactions
Polish 54.5 KB
2016-07-04 14:22
Current report 62 re insiders transactions
Polish 56.0 KB
2016-07-04 14:07
Sopharma monthly June 2016
Polish 27.0 KB
2016-06-28 10:00
Current report 60 re insiders transactions
Polish 57.0 KB
2016-06-21 13:45
Notification - proxy voting on the Annual General Meeting
Polish 50.0 KB
2016-06-20 17:46
MINUTES OF THE ANNUAL GENERAL MEETING
Polish 312.3 KB
2016-06-20 14:04
Current report 57 re insiders transactions
Polish 54.5 KB
2016-06-20 11:47
Current report 56 re insiders transactions
Polish 70.5 KB
2016-06-17 17:24
Notification AGM
Polish 57.5 KB
2016-06-17 16:10
Current report 54 SPH AGM - 17.06.2016
Polish 47.0 KB

Automate Your Workflow. Get a real-time feed of all Sopharma AD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Sopharma AD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Sopharma AD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.